Patient Insight and Treatment Expectations in Erectile Dysfunction

• Main Author: Hartmut Porst
• Format: Article
• Language: English
• Published: European Medical Journal 2016-04-01
• Series: European Medical Journal
• Subjects: erectile dysfunction (ed); patient preference; treatment adherence; quality of life; sildenafil; vardenafil; tadalafil; avanafil; oral phosphodiesterase type 5 (pde5) inhibitors
• Online Access: https://emj.emg-health.com/wp-content/uploads/sites/2/2018/01/Patient-Insight-and-Treatment-Expectations-in-Erectile-Dysfunction.pdf

In the literature, a strong preference towards pharmacological management with oral phosphodiesterase type 5 (PDE5) inhibitors has been demonstrated in men with erectile dysfunction (ED) versus other methods. However, following pharmacological management, a large proportion of men with ED discontinue treatment prematurely. Therefore, a better understanding of the expectations from, and demands on modern ED management from both the patients and their partners is needed in order to identify factors that may improve outcomes, patient adherence, and patient satisfaction with therapy. Thus, we will present new findings on patient and partner satisfaction and preferences, and discuss how the current pharmacological armamentarium can answer these needs.